Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Ventyx Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 138
- −10 vs. Q2 2023
- Shares held
- 54.6M
- +2.73M (+5.3%) vs. Q2 2023
- Total value
- $1.90B
- +$195.6M (+11.5%) vs. Q2 2023
- New holders
- 13
- 60 more added
- Sold out
- 23
- 44 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTYX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $21.0K |
| Q4 2025 | 139 | $471.6M |
| Q3 2025 | 110 | $136.4M |
| Q2 2025 | 114 | $95.1M |
| Q1 2025 | 116 | $51.1M |
| Q4 2024 | 124 | $119.2M |
| Q3 2024 | 118 | $114.4M |
| Q2 2024 | 117 | $132.3M |
| Q1 2024 | 126 | $323.8M |
| Q4 2023 | 121 | $106.8M |
| Q3 2023 | 138 | $1.90B |
| Q2 2023 | 150 | $1.73B |
| Q1 2023 | 146 | $1.67B |
| Q4 2022 | 125 | $1.40B |
| Q3 2022 | 104 | $1.37B |
| Q2 2022 | 63 | $423.5M |
| Q1 2022 | 55 | $448.4M |
| Q4 2021 | 46 | $619.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Ventyx Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 248,515 | $8.63M | 0.08% | +153,000+160.2% | Added |
| Victory Capital Management Inc | 259,634 | $9.02M | 0.01% | −79,066−23.3% | Reduced |
| Jefferies Financial Group Inc. | 273,574 | $9.50M | 0.24% | +150,000+121.4% | Added |
| GMT Capital Corp | 280,600 | $9.75M | 0.37% | 00.0% | Unchanged |
| Morgan Stanley | 284,107 | $9.87M | 0.00% | −230,184−44.8% | Reduced |
| Marshall Wace, LLP | 334,738 | $11.6M | 0.02% | +94,738+39.5% | Added |
| OrbiMed Advisors LLC | 340,384 | $11.8M | 0.27% | −200,600−37.1% | Reduced |
| Avidity Partners Management LP | 354,900 | $12.3M | 0.50% | −337,600−48.8% | Reduced |
| Charles Schwab Investment Management Inc | 363,385 | $12.6M | 0.00% | +107,997+42.3% | Added |
| Nuveen Asset Management, LLC | 387,272 | $13.4M | 0.00% | +21,158+5.8% | Added |
| Artal Group S.A. | 405,239 | $14.1M | 0.61% | −3,280−0.8% | Reduced |
| Northern Trust Corp | 418,938 | $14.5M | 0.00% | +35,581+9.3% | Added |
| Vivo Capital, LLC | 422,075 | $14.7M | 1.81% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 430,000 | $14.9M | 2.12% | +80,000+22.9% | Added |
| Qiming U.S. Ventures Management, LLC | 686,370 | $23.8M | 31.65% | −60,000−8.0% | Reduced |
| venBio Partners LLC | 758,800 | $26.4M | 7.47% | +334,768+78.9% | Added |
| TCG Crossover Management, LLC | 815,724 | $28.3M | 4.17% | 00.0% | Unchanged |
| Boxer Capital, LLC | 850,000 | $29.5M | 1.57% | 00.0% | Unchanged |
| Redmile Group, LLC | 929,900 | $32.3M | 1.54% | −10,593−1.1% | Reduced |
| Pictet Asset Management Holding SA | 969,979 | $33.7M | 0.04% | +969,979 | New |
| Geode Capital Management, LLC | 975,810 | $33.9M | 0.00% | +200,090+25.8% | Added |
| Adage Capital Partners GP, L.L.C. | 987,970 | $34.3M | 0.08% | +895,000+962.7% | Added |
| T. Rowe Price Investment Management, Inc. | 1,032,846 | $35.9M | 0.03% | +123,124+13.5% | Added |
| State Street Corp | 1,096,519 | $38.1M | 0.00% | +56,421+5.4% | Added |
| Driehaus Capital Management LLC | 1,107,631 | $38.5M | 0.50% | +144,435+15.0% | Added |
| Loomis Sayles & Co L P | 1,257,973 | $43.7M | 0.08% | +259,736+26.0% | Added |
| Point72 Asset Management, L.P. | 1,298,493 | $45.1M | 0.15% | +499,493+62.5% | Added |
| Wellington Management Group LLP | 1,342,977 | $46.6M | 0.01% | −6,655−0.5% | Reduced |
| Holocene Advisors, LP | 1,598,691 | $55.5M | 0.25% | +61,607+4.0% | Added |
| Goldman Sachs Group Inc | 1,615,546 | $56.1M | 0.01% | +47,726+3.0% | Added |
| Janus Henderson Group PLC | 1,706,784 | $59.3M | 0.04% | −59,523−3.4% | Reduced |
| Lord, Abbett & Co. LLC | 1,729,464 | $60.1M | 0.22% | −587,711−25.4% | Reduced |
| Vanguard Group Inc | 2,662,671 | $92.5M | 0.00% | +277,906+11.7% | Added |
| Capital International Investors | 2,727,852 | $94.7M | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,939,481 | $102.1M | 0.11% | +152,349+5.5% | Added |
| BlackRock Inc. | 3,628,220 | $126.0M | 0.00% | +401,648+12.4% | Added |
| Price T Rowe Associates Inc | 3,826,555 | $132.9M | 0.02% | −122,738−3.1% | Reduced |
| FMR LLC | 8,677,529 | $301.4M | 0.03% | +124,298+1.5% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −617,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −249,273−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −100,696−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −57,800−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −47,112−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −31,747−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −24,131−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,397−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −21,300−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,219−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −13,119−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,087−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −9,184−100.0% | Sold out |
| Moran Wealth Management, LLC | 0 | $0 | 0.00% | −8,312−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −7,746−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −7,741−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −6,994−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −4,179−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −1,060−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −456−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Tiaa, FSB | – | – | – | – | Not filed |